Skip to content
HowShorted

Korro Bio, Inc. short interest in 2020

In 2020, Korro Bio, Inc.'s disclosed short interest ran from 6.90% of shares outstanding on 15 Jan 2020 to 13.75% on 31 Dec 2020, a change of +6.85 percentage points. The year's high was 13.81% on 15 Jul 2020 and its low 6.54% on 31 Jan 2020, averaging 10.16% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.46 days on 14 Aug 2020. Full history: Korro Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Korro Bio, Inc. in 2020

2020 in figures

Start of year
6.90% (15 Jan 2020)
End of year
13.75% (31 Dec 2020)
Change
+6.85 pp
High
13.81% (15 Jul 2020)
Low
6.54% (31 Jan 2020)
Average
10.16%
Highest days to cover
38.46 (14 Aug 2020)
SEC filings marked
8

Every report in 2020

Korro Bio, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20206.90%12.43
31 Jan 20206.54%15.22
14 Feb 20207.05%20.82
28 Feb 20206.95%25.76
13 Mar 20207.54%27.01
31 Mar 20207.68%24.2910-K filed, results (8-K)
15 Apr 20207.61%16.76
30 Apr 20207.74%20.42
15 May 20207.97%24.2210-Q filed, results (8-K)
29 May 20208.35%12.87
15 Jun 20208.97%13.44
30 Jun 202013.71%6.42
15 Jul 202013.81%34.63
31 Jul 202011.67%33.60
14 Aug 202011.67%38.4610-Q filed, results (8-K)
31 Aug 202011.55%36.15
15 Sep 202012.23%25.27
30 Sep 202012.50%16.63
15 Oct 202012.03%33.84
30 Oct 202011.77%36.06
13 Nov 202011.84%26.29
30 Nov 202011.99%18.9310-Q filed, results (8-K)
15 Dec 202012.13%28.90
31 Dec 202013.75%11.43

See also: Korro Bio, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.